BRG Borregaard

Borregaard ASA: Annual general meeting – new date

Borregaard ASA: Annual general meeting – new date

In light of the situation related to covid-19 and current restrictions on travels and meetings, the Board of Borregaard has today decided to postpone the Annual General Meeting. The new date is Monday 15 June 2020. The financial calendar will be updated accordingly.

As a consequence of the postponed Annual General Meeting the proposed ordinary dividend of NOK 2.30 per share will be paid out at a later date than previously announced (see stock exchange notice of 5 February 2020). A separate notice containing payment date and other key information related to the cash dividend will be sent out shortly.

Sarpsborg, 18 March 2020

Contact:

Jørn Syvertsen, Director Investor Relations,

This information is subject to the disclosure requirements pursuant to Section 5 – 12 of the Norwegian Securities Trading Act.

EN
18/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

Niclas Gehin
  • Niclas Gehin

Borregaard (Buy, TP: NOK230.00) - Agricultural products boost Q1 EPS

The solid Q1 results included a 6% EBITDA beat, led by record-high sales and profits from growing agricultural product sales – management said the underlying trend was driven by demand for ‘green’ food production products. Our 2026–2027e EPS are largely unchanged (tweaked by c1%) as the USD depreciation and lowered bioethanol price guidance largely offset the higher agricultural product sales. We still see this as an attractive entry point, and reiterate our BUY and NOK230 target price.

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye
 PRESS RELEASE

Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter

Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter Borregaard’s operating revenues increased to NOK 2,036 million (NOK 1,975 million)2 in the 1st quarter of 2025. EBITDA1 reached NOK 511 million (NOK 442 million). The result in BioSolutions increased, BioMaterials had a result in line with the corresponding quarter last year and Fine Chemicals had a lower result. Strong sales to agriculture were the main reason for the all-time high result in BioSolutions. For BioMaterials, higher sales prices were offset by lower sales volume, increased wood costs, and cost increases in general...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch